{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:58:25Z","timestamp":1790949505454,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160120"],"award-info":[{"award-number":["82160120"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71311-8","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T11:02:37Z","timestamp":1725966157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["FABP4 deficiency ameliorates alcoholic steatohepatitis in mice via inhibition of p53 signaling pathway"],"prefix":"10.1038","volume":"14","author":[{"given":"Hao","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guandou","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenya","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fudi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"issue":"5","key":"71311_CR1","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1002\/hep.31583","volume":"73","author":"S Asrani","year":"2021","unstructured":"Asrani, S. et al. Reducing the global burden of alcohol-associated liver disease: A blueprint for action. Hepatology 73(5), 2039\u20132050. https:\/\/doi.org\/10.1002\/hep.31583 (2021).","journal-title":"Hepatology"},{"issue":"1","key":"71311_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"H Seitz","year":"2018","unstructured":"Seitz, H. et al. Alcoholic liver disease. Nat. Rev. Dis. Primers 4(1), 16. https:\/\/doi.org\/10.1038\/s41572-018-0014-7 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"71311_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jhep.2018.12.003","volume":"70","author":"C Lackner","year":"2019","unstructured":"Lackner, C. & Tiniakos, D. Fibrosis and alcohol-related liver disease. J. Hepatol. 70(2), 294\u2013304. https:\/\/doi.org\/10.1016\/j.jhep.2018.12.003 (2019).","journal-title":"J. Hepatol."},{"issue":"2","key":"71311_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jhep.2018.10.036","volume":"70","author":"T Hydes","year":"2019","unstructured":"Hydes, T. et al. Treating alcohol-related liver disease from a public health perspective. J. Hepatol. 70(2), 223\u2013236. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.036 (2019).","journal-title":"J. Hepatol."},{"issue":"4","key":"71311_CR5","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.cell.2020.07.027","volume":"182","author":"B Li","year":"2020","unstructured":"Li, B. et al. SnapShot: FABP functions. Cell 182(4), 1066-1066.e1061. https:\/\/doi.org\/10.1016\/j.cell.2020.07.027 (2020).","journal-title":"Cell"},{"issue":"6","key":"71311_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd2589","volume":"7","author":"M Furuhashi","year":"2008","unstructured":"Furuhashi, M. & Hotamisligil, G. Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov. 7(6), 489\u2013503. https:\/\/doi.org\/10.1038\/nrd2589 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"71311_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrendo.2015.122","volume":"11","author":"G Hotamisligil","year":"2015","unstructured":"Hotamisligil, G. & Bernlohr, D. Metabolic functions of FABPs\u2014Mechanisms and therapeutic implications. Nat. Rev. Endocrinol. 11(10), 592\u2013605. https:\/\/doi.org\/10.1038\/nrendo.2015.122 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"71311_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100975","volume":"14","author":"N Attal","year":"2021","unstructured":"Attal, N. et al. Fatty acid binding protein-4 promotes alcohol-dependent hepatosteatosis and hepatocellular carcinoma progression. Transl. Oncol. 14(1), 100975. https:\/\/doi.org\/10.1016\/j.tranon.2020.100975 (2021).","journal-title":"Transl. Oncol."},{"key":"71311_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biology11111613","author":"N Attal","year":"2022","unstructured":"Attal, N. et al. Role of AMPK-SREBP signaling in regulating fatty acid binding-4 (FABP4) expression following ethanol metabolism. Biology (Basel) https:\/\/doi.org\/10.3390\/biology11111613 (2022).","journal-title":"Biology (Basel)"},{"issue":"6","key":"71311_CR10","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/acer.14828","volume":"46","author":"N Attal","year":"2022","unstructured":"Attal, N. et al. Cytochrome P450 2E1-dependent hepatic ethanol metabolism induces fatty acid-binding protein 4 and steatosis. Alcohol Clin. Exp. Res. 46(6), 928\u2013940. https:\/\/doi.org\/10.1111\/acer.14828 (2022).","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"5","key":"71311_CR11","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1053\/j.gastro.2020.12.008","volume":"160","author":"V Massey","year":"2021","unstructured":"Massey, V. et al. Integrated multiomics reveals glucose use reprogramming and identifies a novel hexokinase in alcoholic hepatitis. Gastroenterology 160(5), 1725-1740.e1722. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.008 (2021).","journal-title":"Gastroenterology"},{"issue":"4","key":"71311_CR12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jhep.2021.05.041","volume":"75","author":"M Bou Saleh","year":"2021","unstructured":"Bou Saleh, M. et al. Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis. J. Hepatol. 75(4), 912\u2013923. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.041 (2021).","journal-title":"J. Hepatol."},{"issue":"5","key":"71311_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/atvbaha.116.307225","volume":"36","author":"M Furuhashi","year":"2016","unstructured":"Furuhashi, M. et al. Local production of fatty acid-binding protein 4 in epicardial\/perivascular fat and macrophages is linked to coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 36(5), 825\u2013834. https:\/\/doi.org\/10.1161\/atvbaha.116.307225 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"71311_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124054","author":"B Simran","year":"2023","unstructured":"Simran, B., Pooja, & Sudesh Kumar, Y. CRISPR-Cas for genome editing: Classification, mechanism, designing and applications. Int. J. Biol. Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124054 (2023).","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"71311_CR15","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1053\/j.gastro.2015.06.009","volume":"149","author":"M Xu","year":"2015","unstructured":"Xu, M. et al. Fat-specific protein 27\/CIDEC promotes development of alcoholic steatohepatitis in mice and humans. Gastroenterology 149(4), 1030-1041.e1036. https:\/\/doi.org\/10.1053\/j.gastro.2015.06.009 (2015).","journal-title":"Gastroenterology"},{"key":"71311_CR16","doi-asserted-by":"publisher","DOI":"10.18129\/B9.bioc.sva","author":"J Edu","year":"2013","unstructured":"Edu, J., Johnson, W. E. & Edu, A. Surrogate variable analysis. Dissert. Theses Gradworks https:\/\/doi.org\/10.18129\/B9.bioc.sva (2013).","journal-title":"Dissert. Theses Gradworks"},{"issue":"4","key":"71311_CR17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jhep.2012.11.042","volume":"58","author":"Z Derdak","year":"2013","unstructured":"Derdak, Z. et al. Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease. J. Hepatol. 58(4), 785\u2013791. https:\/\/doi.org\/10.1016\/j.jhep.2012.11.042 (2013).","journal-title":"J. Hepatol."},{"issue":"3","key":"71311_CR18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","volume":"62","author":"M Pawlak","year":"2015","unstructured":"Pawlak, M., Lefebvre, P. & Staels, B. Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J. Hepatol. 62(3), 720\u2013733. https:\/\/doi.org\/10.1016\/j.jhep.2014.10.039 (2015).","journal-title":"J. Hepatol."},{"key":"71311_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000380952","volume":"95","author":"N Zhang","year":"2015","unstructured":"Zhang, N. et al. Fenofibrate treatment attenuated chronic endoplasmic reticulum stress in the liver of nonalcoholic fatty liver disease mice. Pharmacology 95, 173\u2013180. https:\/\/doi.org\/10.1159\/000380952 (2015).","journal-title":"Pharmacology"},{"issue":"10","key":"71311_CR20","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","volume":"25","author":"A Kauppinen","year":"2013","unstructured":"Kauppinen, A. et al. Antagonistic crosstalk between NF-\u03baB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal. 25(10), 1939\u20131948. https:\/\/doi.org\/10.1016\/j.cellsig.2013.06.007 (2013).","journal-title":"Cell Signal."},{"issue":"2","key":"71311_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jhep.2020.02.017","volume":"73","author":"L Weichselbaum","year":"2020","unstructured":"Weichselbaum, L. et al. Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis. J. Hepatol. 73(2), 303\u2013314. https:\/\/doi.org\/10.1016\/j.jhep.2020.02.017 (2020).","journal-title":"J. Hepatol."},{"issue":"2","key":"71311_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jhep.2018.10.023","volume":"70","author":"B Gao","year":"2019","unstructured":"Gao, B. et al. Inflammatory pathways in alcoholic steatohepatitis. J. Hepatol. 70(2), 249\u2013259. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.023 (2019).","journal-title":"J. Hepatol."},{"issue":"6","key":"71311_CR23","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","volume":"26","author":"M Liao","year":"2020","unstructured":"Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 26(6), 842\u2013844. https:\/\/doi.org\/10.1038\/s41591-020-0901-9 (2020).","journal-title":"Nat. Med."},{"issue":"12","key":"71311_CR24","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/nm.2067","volume":"15","author":"E Erbay","year":"2009","unstructured":"Erbay, E. et al. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat. Med. 15(12), 1383\u20131391. https:\/\/doi.org\/10.1038\/nm.2067 (2009).","journal-title":"Nat. Med."},{"issue":"3","key":"71311_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1001\/jamainternmed.2018.6536","volume":"179","author":"B Lee","year":"2019","unstructured":"Lee, B. et al. National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States. JAMA Intern. Med. 179(3), 340\u2013348. https:\/\/doi.org\/10.1001\/jamainternmed.2018.6536 (2019).","journal-title":"JAMA Intern. Med."},{"key":"71311_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155528","author":"L Jian","year":"2023","unstructured":"Jian, L. et al. Targeting FABP4 in elderly mice rejuvenates liver metabolism and ameliorates aging-associated metabolic disorders. Metabolism https:\/\/doi.org\/10.1016\/j.metabol.2023.155528 (2023).","journal-title":"Metabolism"},{"key":"71311_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166810","author":"Z Cui","year":"2023","unstructured":"Cui, Z. et al. FABP4 in LSECs promotes CXCL10-mediated macrophage recruitment and M1 polarization during NAFLD progression. Biochim. Biophys. Acta Mol. Basis Dis. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166810 (2023).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"71311_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56235-y","author":"C Audrey","year":"2019","unstructured":"Audrey, C. et al. FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-019-56235-y (2019).","journal-title":"Sci. Rep."},{"key":"71311_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-022-01764-1","author":"W Jonas","year":"2023","unstructured":"Jonas, W. et al. Fatty acid-binding protein-4 (FABP4) and matrix metalloproteinase-9 (MMP9) as predictive values for nonalcoholic steatohepatitis (NASH). Lipids Health Dis. https:\/\/doi.org\/10.1186\/s12944-022-01764-1 (2023).","journal-title":"Lipids Health Dis."},{"issue":"10","key":"71311_CR30","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrc2715","volume":"9","author":"K Vousden","year":"2009","unstructured":"Vousden, K. & Ryan, K. p53 and metabolism. Nat. Rev. Cancer 9(10), 691\u2013700. https:\/\/doi.org\/10.1038\/nrc2715 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"71311_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2021.03.010","volume":"85","author":"Y Liu","year":"2022","unstructured":"Liu, Y. & Gu, W. The complexity of p53-mediated metabolic regulation in tumor suppression. Semin. Cancer Biol. 85, 4\u201332. https:\/\/doi.org\/10.1016\/j.semcancer.2021.03.010 (2022).","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"71311_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jhep.2010.08.007","volume":"54","author":"Z Derdak","year":"2011","unstructured":"Derdak, Z. et al. Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease. J. Hepatol. 54(1), 164\u2013172. https:\/\/doi.org\/10.1016\/j.jhep.2010.08.007 (2011).","journal-title":"J. Hepatol."},{"issue":"3","key":"71311_CR33","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1152\/physrev.00022.2011","volume":"92","author":"R Nogueiras","year":"2012","unstructured":"Nogueiras, R. et al. Sirtuin 1 and sirtuin 3: Physiological modulators of metabolism. Physiol. Rev. 92(3), 1479\u20131514. https:\/\/doi.org\/10.1152\/physrev.00022.2011 (2012).","journal-title":"Physiol. Rev."},{"issue":"1","key":"71311_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jhep.2012.08.008","volume":"58","author":"R Castro","year":"2013","unstructured":"Castro, R. et al. miR-34a\/SIRT1\/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. J. Hepatol. 58(1), 119\u2013125. https:\/\/doi.org\/10.1016\/j.jhep.2012.08.008 (2013).","journal-title":"J. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71311-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71311-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71311-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T11:07:43Z","timestamp":1725966463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71311-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71311"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71311-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4292137\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21135"}}